{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:27:30Z","timestamp":1789165650876,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Few studies have assessed the relationship between poverty and\u00a0the\u00a0risk of infection with antimicrobial resistant organisms (AROs). We sought to identify, appraise, and synthesize the available published Canadian literature that analyzes living in poverty and risk of AROs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A structured narrative review methodology was used, including a systematic search of three databases:\u00a0MedLINE, EMBASE and Web of Science for articles pertaining to poverty, and infection with AROs in Canada between 1990 and 2020. Poverty\u00a0was broadly defined to include economic measures and associated\u00a0social determinants of health. Based on inclusion and exclusion criteria, there were 889 initial articles, and 43 included in the final review. The final articles were extracted using a standard format and appraised\u00a0using\u00a0the Joanna Briggs\u00a0Institute Levels of Evidence\u00a0framework.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 43 studies, 15 (35%) related to\u202fmethicillin-resistant\u202f<jats:italic>Staphylococcus aureus<\/jats:italic>\u202f(MRSA). One study found a 73% risk reduction (RR 0.27, 95%CI 0.19\u20130.39, p\u2009=\u2009\u2009&lt;\u20090.0001) in\u202fcommunity-acquired MRSA (CA-MRSA)\u00a0infection for each\u00a0$100,000 income increase.\u00a0Results pertaining to\u00a0homelessness and MRSA\u00a0suggested transmission was related to patterns of frequent drug use, skin-to-skin contact and sexual contact more than shelter contact.\u00a0Indigenous persons have high rates of CA-MRSA, with more rooms in the house being a significant protective factor (OR 0.86, <jats:italic>p<\/jats:italic>\u2009=\u20090.023). One study found household income over $60,000 (OR 0.83, <jats:italic>p<\/jats:italic>\u2009=\u20090.039) in univariate analysis and higher maternal education (OR 0.76, 95%CI 0.63\u20130.92, <jats:italic>p<\/jats:italic>\u2009=\u20090.005) in multivariate analysis were protective\u00a0for\u00a0otitis media due to an ARO among children.\u00a0Twenty\u00a0of 43 (46.5%) articles pertained to tuberculosis (TB). Foreign-born persons\u00a0were\u00a0four times more likely to have resistant TB compared to Canadian-born persons. None of the 20 studies\u202fused income in their analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There is an association between higher income and protection from CA-MRSA. Mixed results exist regarding the impact of homelessness and MRSA, demonstrating a nuanced relationship with behavioural risk factors.\u00a0Higher income and maternal education were associated with reduced ARO-associated acute otitis media in children in one study.\u00a0We do not have a robust understanding of the social measures of marginalization related to being foreign-born that contribute to higher rates of resistant TB infection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01059-1","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T13:10:05Z","timestamp":1643029805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Dimensions of poverty as risk factors for antimicrobial resistant organisms in Canada: a structured narrative review"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0834-4150","authenticated-orcid":false,"given":"Teagan","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richelle","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Chavda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Conly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"1059_CR1","unstructured":"Expert Panel on the Potential SocioEconomic Impacts of Antimicrobial Resistance in Canada. When Antibiotics Fail. Council of Canadian Academies. 2019. https:\/\/cca-reports.ca\/reports\/the-potential-socio-economic-impacts-of-antimicrobial-resistance-in-canada\/. Accessed 3 Apr 2020."},{"issue":"76","key":"1059_CR2","first-page":"1","volume":"7","author":"V Alividza","year":"2018","unstructured":"Alividza V, Mariano V, Ahmad R, et al. Investigating the impact of poverty on colonization and infection with drug-resistant organisms in humans: a systematic review. Infect Dis Poverty. 2018;7(76):1\u201311.","journal-title":"Infect Dis Poverty"},{"key":"1059_CR3","unstructured":"Statistics Canada. Dimensions of Poverty Hub. 2020. https:\/\/www.statcan.gc.ca\/eng\/topics-start\/poverty. Accessed 3 Apr 2020."},{"key":"1059_CR4","unstructured":"Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party October 2013. Levels of evidence. 2013. https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI-Levels-of-evidence_2014_0.pdf Accessed 25 Jul 2021."},{"key":"1059_CR5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/s12889-016-3220-9","volume":"16","author":"P Daley","year":"2016","unstructured":"Daley P, Bajgai J, Penney C, Williams K, Whitney H, Golding GR, et al. A cross sectional study of animal and human colonization with methicillin-resistant Staphylococcus aureus (MRSA) in an Aboriginal community. BMC Public Health. 2016;16:595.","journal-title":"BMC Public Health"},{"issue":"5","key":"1059_CR6","first-page":"1","volume":"34","author":"A Dalloo","year":"2008","unstructured":"Dalloo A, Sobol I, Palacios C, Mulvey M, Gravel D, Panaro L. Investigation of community-associated methicillin-resistant Staphylococcus aureus in a remote northern community, Nunavut. Canada Can Commun Dis Rep. 2008;34(5):1\u20137.","journal-title":"Canada Can Commun Dis Rep"},{"issue":"10","key":"1059_CR7","first-page":"646","volume":"15","author":"J Embil","year":"1994","unstructured":"Embil J, Ramotar K, Romance L, Alfa M, Conly J, Cronk S, et al. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990\u20131992. Infect Control Hospital Epidemiol. 1994;15(10):646\u201351.","journal-title":"Infect Control Hospital Epidemiol"},{"issue":"2","key":"1059_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1503\/cmaj.051565","volume":"175","author":"M Gilbert","year":"2006","unstructured":"Gilbert M, MacDonald J, Gregson D, Siushansian J, Zhang K, Elsayed S, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ. 2006;175(2):149\u201354.","journal-title":"CMAJ"},{"issue":"6","key":"1059_CR9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1155\/2007\/597123","volume":"18","author":"M Gilbert","year":"2007","unstructured":"Gilbert M, MacDonald J, Louie M, Gregson D, Zhang K, Elsayed S, et al. Prevalence of USA300 colonization or infection and associated variables during an outbreak of community-associated methicillin-resistant Staphylococcus aureus in a marginalized urban population. Can J Infect Dis Med Microbiol. 2007;18(6):357\u201362.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"1059_CR10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1186\/s12889-019-7169-3","volume":"19","author":"VC Gill","year":"2019","unstructured":"Gill VC, Ma I, Guo M, Gregson DB, Naugler C, Church DL. Sociodemographic and geospatial associations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in a large Canadian city: an 11 year retrospective study. BMC Public Health. 2019;19(1):914.","journal-title":"BMC Public Health"},{"issue":"1","key":"1059_CR11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12879-020-4842-1","volume":"20","author":"D Jeong","year":"2020","unstructured":"Jeong D, Nguyen HNT, Tyndall M, Schreiber YS. Antibiotic use among twelve Canadian First Nations communities: a retrospective chart review of skin and soft tissue infections. BMC Infect Dis. 2020;20(1):118.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1059_CR12","first-page":"99","volume":"19","author":"M Kirlew","year":"2014","unstructured":"Kirlew M, Rea S, Schroeter A, Makahnouk D, Hamilton M, Brunton N, et al. Invasive CA-MRSA in northwestern Ontario: a 2-year prospective study. Can J Rural Med. 2014;19(3):99\u2013102.","journal-title":"Can J Rural Med"},{"issue":"7","key":"1059_CR13","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/JCM.00505-14","volume":"52","author":"V Li","year":"2014","unstructured":"Li V, Chui L, Simmonds K, Nguyen T, Golding GR, Yacoub W, et al. Emergence of new CMRSA7\/USA400 methicillin-resistant Staphylococcus aureus spa types in Alberta, Canada, from 2005 to 2012. J Clin Microbiol. 2014;52(7):2439\u201346.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"1059_CR14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1155\/2005\/698181","volume":"16","author":"CL Main","year":"2005","unstructured":"Main CL, Jayaratne P, Haley A, Rutherford C, Smaill F, Fisman DN. Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can J Infect Dis Med Microbiol. 2005;16(6):343\u20138.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"1059_CR15","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1155\/2013\/169409","volume":"24","author":"J Muileboom","year":"2013","unstructured":"Muileboom J, Hamilton M, Parent K, Makahnouk D, Kirlew M, Saginur R, et al. Community-associated methicillin-resistant Staphylococcus aureus in northwest Ontario: A five-year report of incidence and antibiotic resistance. Can J Infect Dis Med Microbiol. 2013;24(2):e42\u20134.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"1059_CR16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/500628","volume":"27","author":"M Ofner-Agostini","year":"2006","unstructured":"Ofner-Agostini M, Simor AE, Bryce E, McGeer A, Paton S. Methicillin-resistant Staphylococcus aureus in Canadian aboriginal people. Infect Control Hosp Epidemiol. 2006;27(2):204\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"1059_CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1155\/2007\/264257","volume":"18","author":"TA Szakacs","year":"2007","unstructured":"Szakacs TA, Toye B, Turnbull JM, Muckle W, Roth VR. Prevalence of methicillin-resistant Staphylococcus aureus in a Canadian inner-city shelter. Can J Infect Dis Med Microbiol. 2007;18(4):249\u201352.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"6","key":"1059_CR18","first-page":"335","volume":"14","author":"JV Vayalumkal","year":"2012","unstructured":"Vayalumkal JV, Suh KN, Toye B, Ramotar K, Saginur R, Roth VR. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA): an affliction of the underclass. CJEM. 2012;14(6):335\u201343.","journal-title":"CJEM"},{"issue":"6","key":"1059_CR19","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1128\/JCM.43.6.2830-2836.2005","volume":"43","author":"JL Wylie","year":"2005","unstructured":"Wylie JL, Nowicki DL. Molecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba. Canada J Clin Microbiol. 2005;43(6):2830\u20136.","journal-title":"Canada J Clin Microbiol"},{"issue":"4","key":"1059_CR20","first-page":"45","volume":"31","author":"Public Health Agency of Canada","year":"2005","unstructured":"Public Health Agency of Canada. Tuberculosis in Canada 2002: executive summary. Can Commun Dis Rep. 2005;31(4):45\u20136.","journal-title":"Can Commun Dis Rep"},{"issue":"5","key":"1059_CR21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1155\/2000\/457905","volume":"7","author":"M Avendano","year":"2000","unstructured":"Avendano M, Goldstein RS. Multidrug-resistant tuberculosis: long term follow-up of 40 non-HIV-infected patients. Can Respir J. 2000;7(5):383\u20139.","journal-title":"Can Respir J"},{"issue":"4","key":"1059_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1155\/2004\/826501","volume":"11","author":"VJ Cook","year":"2004","unstructured":"Cook VJ, Manfreda J, Hershfield ES. Tuberculous lymphadenitis in Manitoba: incidence, clinical characteristics and treatment. Can Respir J. 2004;11(4):279\u201386.","journal-title":"Can Respir J"},{"key":"1059_CR23","doi-asserted-by":"crossref","unstructured":"Edwards BD, Edwards J, Cooper R, Kunimoto D, Somayaji R, Fisher D. Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007\u20132017. PLoS ONE. 2020;15(3):e0229691.","DOI":"10.1371\/journal.pone.0229691"},{"issue":"5","key":"1059_CR24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF03404809","volume":"91","author":"E Farzad","year":"2000","unstructured":"Farzad E, Holton D, Long R, FitzGerald M, Laszlo A, Njoo H, et al. Drug resistance study of Mycobacterium tuberculosis in Canada, February 1, 1993 to January 31, 1994. Can J Public Health. 2000;91(5):366\u201370.","journal-title":"Can J Public Health"},{"issue":"7","key":"1059_CR25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/infdis\/jiy278","volume":"218","author":"JL Guthrie","year":"2018","unstructured":"Guthrie JL, Pizzi AD, Roth D, Kong C, Jorgensen D, Rodrigues M, et al. Genotyping and whole-genome sequencing to identify tuberculosis transmission to pediatric patients in British Columbia, Canada, 2005\u20132014. J Infect Dis. 2018;218(7):1155\u201363.","journal-title":"J Infect Dis"},{"issue":"2","key":"1059_CR26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1155\/1999\/456395","volume":"6","author":"A Hersi","year":"1999","unstructured":"Hersi A. Multidrug-resistant tuberculosis in Alberta and British Columbia, 1989 to 1998. Can Respir J. 1999;6(2):155\u201360.","journal-title":"Can Respir J"},{"issue":"4","key":"1059_CR27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.14745\/ccdr.v46i04a05","volume":"46","author":"T Hirama","year":"2020","unstructured":"Hirama T, Sabur N, Derkach P, McNamee J, Song H, Marras T, et al. Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010\u20132016. Can Commun Dis Rep. 2020;46(4):84\u201392.","journal-title":"Can Commun Dis Rep"},{"issue":"3","key":"1059_CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3201\/eid1703.100833","volume":"17","author":"K Khan","year":"2011","unstructured":"Khan K, Rea E, McDermaid C, Stuart R, Chambers C, Wang J, et al. Active tuberculosis among homeless persons, Toronto, Ontario, Canada, 1998\u20132007. Emerg Infect Dis. 2011;17(3):357\u201365.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"1059_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14745\/ccdr.v46i01a02","volume":"46","author":"M LaFreniere","year":"2020","unstructured":"LaFreniere M, Dam D, Strudwick L, McDermott S. Tuberculosis drug resistance in Canada: 2018. Can Commun Dis Rep. 2020;46(1):9\u201315.","journal-title":"Can Commun Dis Rep"},{"issue":"11","key":"1059_CR30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.14745\/ccdr.v44i11a04","volume":"44","author":"M LaFreniere","year":"2018","unstructured":"LaFreniere M, Hussain H, Vachon J. Tuberculosis drug resistance in Canada: 2017. Can Commun Dis Rep. 2018;44(11):290\u20136.","journal-title":"Can Commun Dis Rep"},{"key":"1059_CR31","doi-asserted-by":"crossref","unstructured":"Langlois-Klassen D, Kunimoto D, Saunders LD, Chui L, Boffa J, Menzies D, et al. A population-based cohort study of Mycobacterium tuberculosis Beijing strains: an emerging public health threat in an immigrant-receiving country? PLoS ONE. 2012;7(6):e38431.","DOI":"10.1371\/journal.pone.0038431"},{"issue":"10","key":"1059_CR32","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1086\/598196","volume":"48","author":"R Long","year":"2009","unstructured":"Long R, Chong H, Hoeppner V, Shanmuganathan H, Kowalewska-Grochowska K, Shandro C, et al. Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis. Clin Infect Dis. 2009;48(10):1354\u201360.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1059_CR33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/aje\/153.9.903","volume":"153","author":"R Long","year":"2001","unstructured":"Long R, Chui L, Kakulphimp J, Zielinski M, Talbot J, Kunimoto D. Postsanatorium pattern of antituberculous drug resistance in the Canadian-born population of western Canada: effect of outpatient care and immigration. Am J Epidemiol. 2001;153(9):903\u201311.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1059_CR34","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1007\/BF03405649","volume":"104","author":"R Long","year":"2013","unstructured":"Long R, Langlois-Klassen D. Increase in multidrug-resistant tuberculosis (MDR-TB) in Alberta among foreign-born persons: implications for tuberculosis management. Can J Public Health. 2013;104(1):e22\u20137.","journal-title":"Can J Public Health"},{"issue":"9","key":"1059_CR35","first-page":"1489","volume":"148","author":"R Long","year":"1993","unstructured":"Long R, Manfreda J, Mendella L, Wolfe J, Parker S, Hershfield E. Antituberculous drug resistance in Manitoba from 1980 to 1989. CMAJ. 1993;148(9):1489\u201395.","journal-title":"CMAJ"},{"issue":"3","key":"1059_CR36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1378\/chest.124.3.915","volume":"124","author":"TK Marras","year":"2003","unstructured":"Marras TK, Wilson J, Wang EE, Avendano M, Yang JW. Tuberculosis among Tibetan refugee claimants in Toronto: 1998 to 2000. Chest. 2003;124(3):915\u201321.","journal-title":"Chest"},{"issue":"1","key":"1059_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1371\/journal.pone.0053466","volume":"8","author":"J Minion","year":"2013","unstructured":"Minion J, Gallant V, Wolfe J, Jamieson F, Long R. Multidrug and extensively drug-resistant tuberculosis in Canada 1997\u20132008: demographic and disease characteristics. PLoS ONE. 2013;8(1):8.","journal-title":"PLoS ONE"},{"issue":"5","key":"1059_CR38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/INF.0b013e3181920d4d","volume":"28","author":"W Phongsamart","year":"2009","unstructured":"Phongsamart W, Kitai I, Gardam M, Wang J, Khan K. A population-based study of tuberculosis in children and adolescents in Ontario. Pediatr Infect Dis J. 2009;28(5):416\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"1059_CR39","first-page":"605","volume":"158","author":"P Rivest","year":"1998","unstructured":"Rivest P, Tannenbaum T, Bedard L. Epidemiology of tuberculosis in Montreal. CMAJ. 1998;158(5):605\u20139.","journal-title":"CMAJ"},{"issue":"3","key":"1059_CR40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5876(02)00238-0","volume":"66","author":"EL Ford-Jones","year":"2002","unstructured":"Ford-Jones EL, Friedberg J, McGeer A, Simpson K, Croxford R, Willey B, et al. Microbiologic findings and risk factors for antimicrobial resistance at myringotomy for tympanostomy tube placement - a prospective study of 601 children in Toronto. Int J Pediatr Otorhinolaryngol. 2002;66(3):227\u201342.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1059_CR41","doi-asserted-by":"crossref","unstructured":"Bocking N, Matsumoto CL, Loewen K, Teatero S, Marchand-Austin A, Gordon J, et al. High incidence of invasive group A streptococcal infections in remote Indigenous communities in northwestern Ontario, Canada. Open Forum Infect Dis. 2017;4(1):ofw243.","DOI":"10.1093\/ofid\/ofw243"},{"issue":"1","key":"1059_CR42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3201\/eid1401.071315","volume":"14","author":"MG Bruce","year":"2008","unstructured":"Bruce MG, Deeks SL, Zulz T, Bruden D, Navarro C, Lovgren M, et al. International Circumpolar surveillance system for invasive pneumococcal disease, 1999\u20132005. Emerg Infect Dis. 2008;14(1):25\u201333.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"1059_CR43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1139\/cjm-2019-0210","volume":"65","author":"A Cerqueira","year":"2019","unstructured":"Cerqueira A, Byce S, Tsang RSW, Jamieson FB, Kus JV, Ulanova M. Continuing surveillance of invasive Haemophilus influenzae disease in northwestern Ontario emphasizes the importance of serotype A and non-typeable strains as causes of serious disease: A Canadian immunization research network (CIRN) study. Can J Microbiol. 2019;65(11):805\u201313.","journal-title":"Can J Microbiol"},{"issue":"2","key":"1059_CR44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jinf.2015.04.001","volume":"71","author":"PP Gounder","year":"2015","unstructured":"Gounder PP, Zulz T, Desai S, Stenz F, Rudolph K, Tsang R, et al. Epidemiology of bacterial meningitis in the North American Arctic, 2000\u20132010. J of Infect. 2015;71(2):179\u201387.","journal-title":"J of Infect"},{"key":"1059_CR45","first-page":"72","volume":"2013","author":"M Helferty","year":"1999","unstructured":"Helferty M, Rotondo JL, Martin I, Desai S, The epidemiology of invasive pneumococcal disease in the Canadian North from 1999 to 2010. Int J Circumpolar Health. 1999;2013:72.","journal-title":"Int J Circumpolar Health"},{"issue":"12","key":"1059_CR46","first-page":"701","volume":"27","author":"AL Morse","year":"2013","unstructured":"Morse AL, Goodman KJ, Munday R, Chang HJ, Morse J, Keelan M, et al. A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North. Can J Gastroenterol Hepatol. 2013;27(12):701\u20136.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"9","key":"1059_CR47","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.olq.0000431356.80840.d4","volume":"40","author":"AE Singh","year":"2013","unstructured":"Singh AE, Gratrix J, Read R, Lovgren M, Drews SJ, Romanowski B, et al. Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta. Canada Sex Transm Dis. 2013;40(9):744\u201350.","journal-title":"Canada Sex Transm Dis"},{"key":"1059_CR48","doi-asserted-by":"crossref","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(5).","DOI":"10.1186\/s41073-019-0064-8"},{"key":"1059_CR49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089458","volume":"9","author":"MA Trecker","year":"2014","unstructured":"Trecker MA, Waldner C, Jolly A, Liao M, Gu W, Dillon JA. Behavioral and socioeconomic risk factors associated with probable resistance to ceftriaxone and resistance to penicillin and tetracycline in Neisseria gonorrhoeae in Shanghai. PLoS ONE. 2014;9:","journal-title":"PLoS ONE."},{"key":"1059_CR50","doi-asserted-by":"crossref","unstructured":"Lestari ES, Duerink DO, Hadi U, Severin JA, Nagelkerke NJ, Kuntaman K, et al. Determinants of carriage of resistant\u00a0Staphylococcus aureus\u00a0among\u00a0S. aureus\u00a0carriers in the Indonesian population inside and outside hospitals. Tropical Med Int Health. 2010;15:1235\u201343.","DOI":"10.1111\/j.1365-3156.2010.02600.x"},{"key":"1059_CR51","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/oxfordjournals.aje.a009611","volume":"148","author":"FM Chen","year":"1998","unstructured":"Chen FM, Breiman RF, Farley M, Plikaytis B, Deaver K, Cetron MS. Geocoding and linking data from population-based surveillance and the US census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. Am J Epidemiol. 1998;148:1212\u20138.","journal-title":"Am J Epidemiol"},{"key":"1059_CR52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2016.09.026","volume":"52","author":"G Alvarez-Uria","year":"2016","unstructured":"Alvarez-Uria G, Gandra S, Laxminarayan R. Poverty and prevalence of antimicrobial resistance in invasive isolates. Int J Infect Dis. 2016;52:59\u201361.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"1059_CR53","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S1473-3099(15)00149-8","volume":"15","author":"M Alsan","year":"2015","unstructured":"Alsan M, Schoemaker L, Eggleston K, Kammili N, Kolli P, Bhattacharya J. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis. Lancet Infect Dis. 2015;15(10):1203\u201310.","journal-title":"Lancet Infect Dis"},{"key":"1059_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-89370-9_3","volume-title":"Antimicrobial Resistance in Developing Countries","author":"IN Okeke","year":"2010","unstructured":"Okeke IN. Poverty and root causes of resistance in developing countries. In: Sosa A, Byarugaba D, Am\u00e1bile-Cuevas C, Hsueh PR, Kariuki S, Okeke I, editors. Antimicrobial Resistance in Developing Countries. New York, NY: Springer; 2010. https:\/\/doi.org\/10.1007\/978-0-387-89370-9_3."},{"key":"1059_CR55","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(04)15647-X","volume":"363","author":"JP Bagger","year":"2004","unstructured":"Bagger JP, Zindrou D, Taylor KM. Postoperative infection with methicillin-resistant Staphylococcus aureus and socioeconomic background. Lancet. 2004;363:706\u20138.","journal-title":"Lancet"},{"key":"1059_CR56","doi-asserted-by":"crossref","unstructured":"Michaud CM. Global burden of infectious diseases. Encyclo of Micro. 2009;444\u2013454.","DOI":"10.1016\/B978-012373944-5.00185-1"},{"issue":"8","key":"1059_CR57","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/cid\/civ539","volume":"61","author":"SK Gohil","year":"2015","unstructured":"Gohil SK, Datta R, Cao C, Phelan MJ, Nguyen V, Rowther AA, Huang SS. Impact of hospital population case-mix, including poverty, on hospital all-cause and infection-related 30-day readmission rates. Clin Infect Dis. 2015;61(8):1235\u201343.","journal-title":"Clin Infect Dis"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01059-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T13:28:11Z","timestamp":1643030891000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01059-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01059-1","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"6 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent for participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}